Mycophenolate mofetil - A new treatment for autoimmune hepatitis?

Journal of Hepatology

Volumn 33, Issue 3, 2000, Pages 480-481

  Dhawan, Anil ^a   Mieli Vergani, Giorgina ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

AUTOIMMUNE HEPATITIS; DRUG EFFECT; DRUG MECHANISM; EDITORIAL; GASTROINTESTINAL SYMPTOM; HEMATOLOGIC DISEASE; HUMAN; MAINTENANCE THERAPY; PRIORITY JOURNAL; REMISSION;

EID: 0033840973     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(00)80286-X     Document Type: Editorial

References (27)

1. Plasma cell hepatitis with special attention to steroid therapy
2. Effect of prednisone on the survival of patients with cirrhosis of the liver. A report from the Copenhagen Study Group for Liver Diseases
3. Controlled trial of prednisolone and azathioprine in active chronic hepatitis
4. Lupoid hepatitis: A comparison of 22 cases with other types of liver disease
5. Controlled prospective trial of corticosteroid therapy in active chronic hepatitis
6. Clinical, biochemical and histological remission of severe chronic active liver disease: A controlled study of treatment and early prognosis
7. Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis
8. Corticosteroid-treated chronic active hepatitis in remission: Uncertain prognosis of chronic persistent hepatitis
9. Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis
10. Azathioprine for long-term maintenance of remission in autoimmune hepatitis
11. Cyclosporine treatment of autoimmune chronic active hepatitis
12. Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis
13. Tacrolimus: A potential new treatment for autoimmune chronic hepatitis: Results of an open-label preliminary trial
14. The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine
15. Cyclosphosphamide as alternative immunosuppression therapy for autoimmune hepatitis - Report of three cases
16. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine
17. Ricerche batteriologiche e chimiche sulle alterazoni del mais
18. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil
19. Newer immunosuppressive drugs: A review
20. Prolongation of rat heart allograft survival by RS-61443
21. 2-Morpholino-ethyl Mycophenolic acid (ME-MPA) in the treatment of refractory rheumatoid arthritis (RA)
22. Mycophenolate mofetil for the prevention of acute rejection in primary cadaveric renal allograft recipients. US Renal Transplant Mycophenolate Mofetil Study Group
23. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection
24. A blinded, long-term randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation. Results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group
25. Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation
26. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients
27. Effect of mycophenolic acid on Epstein-Barr virus infection of human B lymphocytes